TOTAL KNEE ARTHROPLASTY MARKET ANALYSIS

Regional Analysis

Global Total Knee Arthroplasty Market- Regional Insights

• North America is expected to be the largest market for total knee arthroplasty during the forecast period, accounting for 39.7% of the market share in 2023. The growth of the market in North America is attributed to factors such as the increasing prevalence of degenerative diseases, accidents and presence of key market players in this region. For instance, on October 30, 2023, Medacta Group S.A., a Swiss company that manufactures innovative, personalized, and sustainable joint replacement solutions, announced the launch of GMK SpheriKA, the world's first KA-optimized femoral component indicated for total knee replacement. On November 2, 2023, GMK SpheriKA will make its global debut at the American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting.
• Europe is expected to be the second-largest market for total knee arthroplasty, accounting for over 23.1% of the market share in 2023. The growth of the market is attributed to presence of skilled healthcare professionals, top-notch healthcare institutes, increasing funding for novel treatment options, and novel product launches in the region. For instance, on October 11, 2023, Johnson & Johnson MedTech, a medical device company, officially launched the VELYS Robotic-Assisted Solution from DePuy Synthes, Johnson & Johnson's Orthopaedics firm, on the European market. In Germany, Belgium, and Switzerland, the VELYS Robotic-Assisted Solution was used to successfully complete total knee surgeries. DePuy Synthes expands its Digital Surgery Platform of connected technologies with this launch, addressing outstanding demands left unmet by previous-generation orthopedic robotics.
• The Asia Pacific is expected to be the fastest-growing market for total knee arthroplasty during the forecast period. The growth of the market in Asia Pacific is attributed to rising medical tourism and growing awareness about total knee arthroplasty. The total knee arthroplasty market in the Asia Pacific region is anticipated to develop at a CAGR of 4.8% over the forecasted period.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East & Africa: GCC Countries, Israel, South Africa, North Africa, and Central Africa and Rest of Middle East